Pratik Jain

2 months ago | insideretail.us | Sean Cao |Tamera Francis |Celene Ignacio |Pratik Jain

Skechers has posted record sales for the last fiscal year, which management attributed to growing demand and effective marketing campaigns. The company’s sales for the year ended December 31 rose 12.1 per cent to $9.04 billion, with direct-to-consumer up 10.7 per cent and wholesale sales up 13.2 per cent. According to COO David Weinberg, the record full-year sales reflected the continued robust global consumer demand supported by effective marketing campaigns.

Sep 20, 2024 | rtinsights.com. | Pratik Jain

The responsible use of GenAI is not merely a choice; it is an imperative. In the absence of clear regulatory guidelines, businesses should develop a discerning understanding of when to harness their power and, equally crucially, when to exercise restraint. OpenAI unveiled ChatGPT on November 30, 2022. It garnered a million users by Dec 4, a number that swelled to 100 million by Jan’23.

Sep 19, 2024 | rtinsights.com | Pratik Jain

The responsible use of GenAI is not merely a choice; it is an imperative. In the absence of clear regulatory guidelines, businesses should develop a discerning understanding of when to harness their power and, equally crucially, when to exercise restraint. OpenAI unveiled ChatGPT on November 30, 2022. It garnered a million users by Dec 4, a number that swelled to 100 million by Jan’23.

Sep 18, 2024 | vmblog.com | Pratik Jain |David Marshall

By Mr Pratik Jain, Senior Technical Architect, Kyvos InsightsSegmentation has been a very effective strategy in marketing. It allows for tailored marketing messages and products to be created for nearly-homogenous groups of customers with similar demographics, interests and buying habits.   Data, analytics and AI level up the game by creating a "segment of one", where each customer is a treated individually, with personalized strategies that go beyond segmentation.

Jul 18, 2024 | gurutrade.com | Pratik Jain |Puyaan Singh |Leroy Leo |Sriraj Kalluvila

July 18 (Reuters) - Abbott Laboratories raised its annual profit forecast on Thursday after its second-quarter earnings edged past Wall Street estimates on double-digit growth in sales of its glucose monitors and strong demand for heart devices. The medical devices unit powered the beat while sales in its diagnostics and nutrition businesses missed estimates. Abbott's shares fell 2.6% to $102.21 in early trading.